Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects

Journal of Clinical Pharmacology

Volumn 38, Issue 1, 1998, Pages 14-21

  Kaplan, Gary B ^b,c   Greenblatt, David J ^a   Ehrenberg, Bruce L ^a   Goddard, Jill E ^a   Harmatz, Jerold S ^a   Shader, Richard I ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; PLACEBO;

ADULT; AGED; AGING; ARTICLE; BETA RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PERFORMANCE; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SELF REPORT;

EID: 0031933393     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04370.x     Document Type: Article

References (28)

1. Dealberto M-J, Seeman T, McAvay GJ, Berkman L: Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 1997;50:357-364.
2. Chrischillies EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, et al: Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerentology 1992;47:M137-M144.
3. Morgan K: Hypnotic drugs, psychomotor performance and ageing. J Sleep Res 1994;3:1-15.
4. Campbell AJ: Drug treatment as a cause of falls in old age: a review of the offending agents. Drugs Aging 1991;1:289-302.
5. Greenblatt DJ, Harmatz JS, Shader RI: Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations. Clin Pharmacokinet 1991;21:165-177, 202-273.
6. Greenblatt DJ, Shader RI, Harmatz JS: Implications of altered drug disposition in the elderly: studies of benzodiazepines. J Clin Pharmacol 1989;29:866-872.
7. von Moltke LL, Greenblatt DJ, Harmatz JS, Shader RI: Psycotropic: drug metabolism in old age: principles and problems of assessment. In, Bloom FE, Kupfer DJ (eds.): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995;1461-1469.
8. Pomara N, Stanley B, Block R, Berchou RC, Stanley M, Greenblatt DJ, et al: Increased sensitivity of the elderly to the central depressant effects of diazepam. J Clin Psychiatry 1985;46:185-187.
9. Reidenberg MM, Levy M, Warner H, Coutino CB, Schwartz MA, Yu G, Cheripko J: Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther 1978;23:371-374.
10. Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI: Sensitivity to triazolam in the elderly. N Engl J Med 1991;324:1691-1698.
11. Shader RI, Greenblatt DJ: Use of benzodiazepines in anxiety disorders. N Engl J Med 1993;328:1398-1405.
12. Greenblatt DJ, Wright CE: Clinical pharmacokinetics of alprazolam: therapeutic implications. Clin Pharmacokinet 1993;24:453-471.
13. Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI: Alprazolam kinetics in the elderly: relation to antipyrine disposition. Arch Gen Psychiat 1983;40:287-290.
14. Kroboth PD, McAuley JW, Smith RB: Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing. Psychopharmacology 1990;100:477-484.
15. Dehlin O, Kullingsojo H, Liden A, Agrell B, Moser G, Olsen I: Pharmacokinetics of alprazolam in geriatric patients with neurotic depression. Pharmacol Toxicol 1991;68:121-124.
16. Charpentier KP, von Moltke LL, Poku JW, Harmatz JS, Shader RI, Greenblatt DJ: Alprazolam hydroxylation by mouse liver microsomes in vitro: effect of age and phenobarbital induction. Biopharmaceut Drug Disp 1997;18:139-144.
17. Bertz RJ, Kroboth PD, Kroboth FJ, Reynolds IJ, Salek F, Wright CE, Smith RB: Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative, and memory effects. J Pharmacol Exp Ther 1997;281:1317-1329.
18. Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI: Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989;45:356-365.
19. Greenblatt DJ, Ehrenberg BL, Gunderman J, Scavone JM, Tai NT, Harmatz JS, Shader RI: Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam. J Pharmacol Exp Ther 1989;250:134-140.
20. Greenblatt DJ, Harmatz JS, Gouthro TA, Locke J, Shader RI: Distinguishing a benzodiazepine agonist (triazolam) from a non-agonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies. Clin Pharmacol Ther 1994;56:100-111.
21. von Moltke LL, Greenblatt DJ, Harmatz JS, Duan SX, Harrel LM, Cotreau-Bibbo MM, et al: Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors, and clinical confirmation of a predicted interaction with ketoconazole. J Pharmacol Exp Ther 1996;276:370-379.
22. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau-Bibbo MM, Harmatz JS, Shader RI: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997;37:693-703.
23. Greenblatt DJ, Javaid JI, Locniskar A, Harmatz JS, Shader RI: Gas chromatographic analysis of alprazolam in plasma: replicability, stability, and specificity. J Chromatogr 1990;534:202-207.
24. Laurijssens BE, Greenblatt DJ: Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin Pharmacokinet 1996;30:52-76.
25. Hinrichs JV, Ghoneim MM: Diazepam, behavior, and aging: increased sensitivity or lower baseline performance? Psychopharmacology 1987;92:100-105.
26. Kaiser L: Adjusting for baseline: change or percentage change? Stat Med 1989;8:1183-1190.
27. Wainer H: Adjusting for differential base rates: Lord's paradox again. Psychol Bull 1991;109:147-151.
28. Robin DW, Hasan SS, Edeki T, Lichtenstein MJ, Shiavi RG, Wood AJJ: Increased baseline sway contributes to increased losses of balance in older people following triazolam. J Am Geriatr Soc 1996;44:300-304.